Anastrozole (Arimidex) Protocol for TRT: Dosing, Timing & Estrogen Management

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Quick Answer: Anastrozole (brand: Arimidex) is the first-line aromatase inhibitor for managing elevated estradiol on TRT. Standard starting dose is 0.25–0.5 mg on each injection day (twice weekly). Never start before your 6-week bloodwork — many men at standard TRT doses do not need an AI at all. Over-suppression of estradiol is as problematic as over-elevation. This guide covers dosing math, timing rules, when to switch to exemestane, and how to monitor.

Why Estradiol Rises on TRT — and Why That Matters

Testosterone aromatises to estradiol (E2) via the enzyme aromatase, which is expressed in adipose tissue, liver, muscle, brain, and testes. On exogenous TRT, supraphysiological peaks of testosterone in the 24–72 hours post-injection drive elevated aromatase substrate availability, resulting in serum E2 that often exceeds the normal male range of 10–40 pg/mL.

The clinical consequences of high E2 on TRT are well documented:

• Gynecomastia — proliferation of breast glandular tissue driven by unopposed E2 at estrogen receptors in breast. Once glandular tissue develops, it does not reverse with AI use; only surgical excision resolves it.
• Water retention and puffiness — E2-driven renal sodium retention; classic “soft” look with puffy face and ankles.
• Reduced libido and ED — paradoxically, very high E2 blunts sexual drive and erection quality, mimicking low T symptoms.
• Emotional lability — mood swings, irritability, and in some men, a depressive pattern.
• Cardiovascular risk — sustained high E2 correlates with elevated SHBG, altered lipid profiles, and thrombotic risk at extremes.

However, E2 is not the enemy — it is essential. Physiological estradiol in men is required for bone mineral density, cognitive function, lipid balance, cardiovascular health, and normal libido. The goal is not elimination — it is optimisation.

Anastrozole vs Exemestane: Choosing the Right AI

Two aromatase inhibitors dominate TRT management: anastrozole (Arimidex) and exemestane (Aromasin). They differ mechanistically and in clinical behaviour in ways that matter for long-term TRT.

Verdict for TRT: Start with anastrozole. Its reversible mechanism makes it easier to titrate — if you over-suppress, stopping it for a few days allows E2 to recover. Switch to exemestane if you experience rebound E2 spikes (common when anastrozole is used less frequently than twice weekly) or if anastrozole causes adverse lipid effects on repeat labs.

Medsbase anastrozole brands: Anastronat, Anabrez, Altraz, Anacan. Exemestane: Aromasin, Armotraz, Xtane.

Anastrozole Dosing Protocol for TRT

Step 1 — Measure Before You Medicate

At 6 weeks post-TRT start, draw mid-cycle bloods (3.5 days after your last injection if you inject twice weekly). Check: total T, free T, estradiol (E2), SHBG, haematocrit, FBC.

Interpret E2 in context of symptoms:

• E2 below 20 pg/mL with symptoms: your AI dose is already too high (or you’re naturally low — do not add more AI)
• E2 20–40 pg/mL, no symptoms: no AI needed
• E2 40–60 pg/mL with mild symptoms (some water retention, mild nipple sensitivity): start at 0.25 mg anastrozole on injection days
• E2 above 60 pg/mL with clear symptoms: start at 0.5 mg anastrozole on injection days

Step 2 — Starting Dose and Timing

For twice-weekly injectors (the most common TRT schedule): take anastrozole on the same days as your testosterone injection. This timing is pharmacologically rational — T peaks drive aromatase substrate, so inhibiting aromatase at the point of highest substrate is logical.

Dosing options:

• 0.25 mg twice weekly (0.5 mg total/week) — conservative starting point; appropriate for leaner men or mild E2 elevation
• 0.5 mg twice weekly (1 mg total/week) — standard starting dose for symptomatic E2 elevation above 50 pg/mL
• Never exceed 1 mg twice weekly without documented severe E2 elevation above 100 pg/mL — doses above this almost always produce low-E2 sides

Step 3 — Re-Check at 4–6 Weeks Post-AI Start

Mid-cycle E2 should now read 20–35 pg/mL. If symptoms resolved and E2 is in range: maintain dose. If E2 is still high with symptoms: increase by 0.125–0.25 mg per injection. If E2 has dropped below 15 pg/mL: reduce or skip doses until symptoms resolve; re-draw in 3 weeks.

Practical Tablet Splitting

Anastrozole is typically supplied as 1 mg tablets. To achieve 0.25 mg doses, quarter the tablet using a pill splitter. Absorption of quartered tablets is clinically acceptable — the margin of error at these small doses does not produce meaningful serum level variation between tablet halves. Crushing and dissolving in alcohol (benzyl alcohol research chemical solution) is used by some — this is pharmacologically sound but outside standard practice and introduces measurement error unless you have accurate liquid dosing equipment.

Recognising Low Estradiol: The AI Over-Suppression Trap

Symptoms of low E2 are frequently misattributed to insufficient testosterone. The overlap is almost complete:

The diagnostic differentiator is joint pain: aching, cracking, dry joints are pathognomonic of low E2 and do not occur with high E2. If you have joint pain on AI, your dose is too high. Reduce immediately and recheck.

When to Switch from Anastrozole to Exemestane

Switch to exemestane (Aromasin) in these situations:

1. Anastrozole resistance — E2 remains above 50 pg/mL despite 0.5 mg twice weekly. Some men express CYP19A1 enzyme variants with reduced anastrozole sensitivity.
2. Rebound spikes — if you inject only once weekly, anastrozole’s reversible mechanism causes E2 to rebound mid-week between doses. Exemestane’s suicidal mechanism prevents this.
3. Adverse lipid effects — anastrozole can modestly lower HDL. If your lipid panel worsens on anastrozole, exemestane’s mild androgenic activity is the better choice.
4. AI holidays — if you periodically cycle off AI, exemestane’s irreversible mechanism means you don’t get sharp E2 rebound on resumption (the enzyme pool must regenerate rather than simply being released from inhibition).

Exemestane dose for TRT: 12.5 mg every other day or 25 mg twice weekly. Aromasin and Xtane are available at Medsbase.

Anastrozole and Fertility on TRT

An important note: anastrozole reduces E2 systemically, including in the testes, where E2 plays a role in spermatogenesis. In men on TRT who are co-administering hCG to preserve spermatogenesis, aggressive AI use can paradoxically impair the spermatogenic benefits of hCG by suppressing intratesticular E2. Recommendation: if on hCG + TRT and fertility matters, keep anastrozole dose conservative (0.25 mg twice weekly maximum) and check E2 regularly.

Frequently Asked Questions

Do I need anastrozole on TRT?

Possibly not. At standard TRT doses (100–150 mg/week), approximately 40–50% of men maintain E2 in the normal range without any AI. You need anastrozole only if your bloodwork shows E2 above 40–50 pg/mL with accompanying symptoms. Never take it prophylactically.

How quickly does anastrozole lower estradiol?

Anastrozole achieves near-maximal enzyme inhibition within 24 hours of the first dose. Serum E2 falls measurably within 48–72 hours. Symptomatic relief from E2-related water retention typically takes 1–2 weeks as retained fluid is mobilised. Full steady-state effect (where dose-E2 relationship stabilises) is reached at 7–14 days.

What happens if I stop anastrozole suddenly?

Since anastrozole is a reversible inhibitor, aromatase activity recovers over 2–4 days after stopping. E2 can rebound, sometimes above baseline levels briefly, before restabilising. If stopping entirely, taper the dose over 2 weeks rather than stopping abruptly to smooth the rebound. If switching to exemestane, no taper is needed — start exemestane immediately.

Can anastrozole cause depression?

Yes. Low estradiol is a recognised cause of depressive symptoms in men. Anastrozole-induced low E2 can produce persistent low mood, anhedonia, and in some men, anxiety. If depression develops on anastrozole, check E2 immediately before attributing it to TRT or adding psychiatric medication. In most cases, the solution is dose reduction.

Is anastrozole safe long-term?

Long-term anastrozole use in men is less studied than in post-menopausal women (where it is used for breast cancer). In the TRT context, the primary long-term concern is bone mineral density loss from chronic E2 suppression. This is mitigated by keeping E2 in the 20–35 pg/mL range rather than aggressively eliminating it. Annual DEXA scanning is advisable for men who have been on AI for more than 2 years.

Every Medsbase order is covered by Reshipment Assurance — if your package doesn’t arrive within the guaranteed window, we reship at no cost. Worldwide discreet shipping. WHO-GMP-certified manufacturers.

Why order anastrozole from Medsbase?

Medsbase stocks multiple WHO-GMP-certified anastrozole brands at a fraction of branded Arimidex prices: Anastronat, Anabrez, Altraz. What you get with Medsbase:

• Pharmaceutical-grade generics — same API, same regulatory standard
• Worldwide discreet shipping with reshipment assurance
• No prescription required to order

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.